These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35107804)

  • 21. Successful treatment of two cases of acute myocarditis with colchicine.
    Kavgacı A; Incedere F; Terlemez S; Kula S
    Cardiol Young; 2023 Sep; 33(9):1741-1742. PubMed ID: 36938910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation.
    Bonaventura A; Vecchié A; Dagna L; Tangianu F; Abbate A; Dentali F
    Inflamm Res; 2022 Mar; 71(3):293-307. PubMed ID: 35113170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful Treatment of Covid-19 Associated Cytokine Release Syndrome with Colchicine. A Case Report and Review of Literature.
    Mansouri N; Marjani M; Tabarsi P; von Garnier C; Mansouri D
    Immunol Invest; 2021 Nov; 50(8):884-890. PubMed ID: 32633162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review.
    Zhang FS; He QZ; Qin CH; Little PJ; Weng JP; Xu SW
    Acta Pharmacol Sin; 2022 Sep; 43(9):2173-2190. PubMed ID: 35046517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colchicine poisoning: the dark side of an ancient drug.
    Finkelstein Y; Aks SE; Hutson JR; Juurlink DN; Nguyen P; Dubnov-Raz G; Pollak U; Koren G; Bentur Y
    Clin Toxicol (Phila); 2010 Jun; 48(5):407-14. PubMed ID: 20586571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunologic Dysregulation and Hypercoagulability as a Pathophysiologic Background in COVID-19 Infection and the Immunomodulating Role of Colchicine.
    Vrachatis DA; Papathanasiou KA; Giotaki SG; Raisakis K; Kossyvakis C; Kaoukis A; Kolokathis F; Deftereos G; Iliodromitis KE; Avramides D; Bogossian H; Siasos G; Giannopoulos G; Reimers B; Lansky A; Tardif JC; Deftereos S
    J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential Role of Colchicine in Combating COVID-19 Cytokine Storm and Its Ability to Inhibit Protease Enzyme of SARS-CoV-2 as Conferred by Molecular Docking Analysis.
    Kamel NA; Ismail NSM; Yahia IS; Aboshanab KM
    Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colchicine for cardiovascular medicine: a systematic review and meta-analysis.
    Casula M; Andreis A; Avondo S; Vaira MP; Imazio M
    Future Cardiol; 2022 Aug; 18(8):647-659. PubMed ID: 35787150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency and severity of COVID-19 in patients with various rheumatic diseases treated regularly with colchicine or hydroxychloroquine.
    Oztas M; Bektas M; Karacan I; Aliyeva N; Dag A; Aghamuradov S; Cevirgen SB; Sari S; Bolayirli M; Can G; Hatemi G; Seyahi E; Ozdogan H; Gul A; Ugurlu S
    J Med Virol; 2022 Jul; 94(7):3431-3437. PubMed ID: 35315100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proactive anti-inflammatory therapy with colchicine in the treatment of advanced stages of new coronavirus infection. The first results of the COLORIT study.
    Mareev VY; Orlova YA; Plisyk AG; Pavlikova EP; Akopyan ZA; Matskeplishvili ST; Malakhov PS; Krasnova TN; Seredenina EM; Potapenko AV; Agapov MA; Asratyan DA; Dyachuk LI; Samokhodskaya LM; Mershina ЕА; Sinitsyn VE; Pakhomov PV; Zhdanova EA; Mareev YV; Begrambekova YL; Kamalov АА
    Kardiologiia; 2021 Mar; 61(2):15-27. PubMed ID: 33734043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colchicine as an anti-inflammatory and cardioprotective agent.
    Gasparyan AY; Ayvazyan L; Yessirkepov M; Kitas GD
    Expert Opin Drug Metab Toxicol; 2015; 11(11):1781-94. PubMed ID: 26239119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interventions for reducing inflammation in familial Mediterranean fever.
    Yin X; Tian F; Wu B; Xu T
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD010893. PubMed ID: 35349164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colchicine anti-inflammatory therapy for non-intensive care unit hospitalized COVID-19 patients: results from a pilot open-label, randomized controlled clinical trial.
    Haroon MZ; Farooq U; Ashraf S; Zeb S; Gillani SY; Malik S; Ali R; Irshad R; Mehmood Z; Abbas Y; Masood A; Ghafoor A; Khalil AT; Asif H; Khan S; Ujjan ID; Nigar R; Livingstone S; Pascual-Figal DA; Togni S; Allergini P; Riva A; Khan A
    J Physiol Pharmacol; 2022 Jun; 73(3):. PubMed ID: 36302537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postoperative atrial fibrillation: role of inflammatory biomarkers and use of colchicine for its prevention.
    Worden JC; Asare K
    Pharmacotherapy; 2014 Nov; 34(11):1167-73. PubMed ID: 25283810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colchicine: An Ancient Drug with Multiple Benefits.
    El Hasbani G; Jawad A; Uthman I
    Curr Pharm Des; 2021; 27(26):2917-2924. PubMed ID: 33100196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colchicine and the heart.
    Imazio M; Nidorf M
    Eur Heart J; 2021 Jul; 42(28):2745-2760. PubMed ID: 33961006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antirheumatic Drugs against COVID-19 from the Perspective of Rheumatologists.
    Kawazoe M; Kihara M; Nanki T
    Pharmaceuticals (Basel); 2021 Dec; 14(12):. PubMed ID: 34959657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-inflammatory therapies for pericardial diseases in the COVID-19 pandemic: safety and potentiality.
    Imazio M; Brucato A; Lazaros G; Andreis A; Scarsi M; Klein A; De Ferrari GM; Adler Y
    J Cardiovasc Med (Hagerstown); 2020 Sep; 21(9):625-629. PubMed ID: 32658005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colchicine: old and new.
    Slobodnick A; Shah B; Pillinger MH; Krasnokutsky S
    Am J Med; 2015 May; 128(5):461-70. PubMed ID: 25554368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colchicine: A potential therapeutic tool against COVID-19. Experience of 5 patients.
    Montealegre-Gómez G; Garavito E; Gómez-López A; Rojas-Villarraga A; Parra-Medina R
    Reumatol Clin (Engl Ed); 2021; 17(7):371-375. PubMed ID: 34301378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.